跳至主要内容
临床试验/NCT02635698
NCT02635698已完成不适用

Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

Société des Produits Nestlé (SPN)9 个研究点 分布在 1 个国家目标入组 330 人开始时间: 2015年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
330
试验地点
9
主要终点
Percent weight change

研究概览

简要总结

Compare percent change in loss of body weight between the OPTIFAST program and a food-based energy-deficit program

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adult males and females between 18 and 70 years
  • •Obese (BMI > 30 kg/m2 and 55 kg/m2)
  • •Non-smokers or smoking cessation > 6 months
  • •< 14 alcoholic beverages per week
  • •Willing and able to give informed consent

排除标准

  • •Active participation in any weight loss program within previous 3 months
  • •Weight changes of > 5% body weight within previous 3 months
  • •Participated in an Optifast program within prior 5 years
  • •Prior bariatric surgery or liposuction
  • •Use of any medication prescribed for weight loss in the past 3 months
  • •Current major disease or GI disease that is poorly controlled (Crohn's, ulcerative colitis)
  • •Type 1 DM
  • •Current ESRD
  • •Current COPD
  • •Any major or active hepatic disease requiring inpatient or outpatient treatment
  • •History of acute pancreatitis in the past year
  • •Active cancer treatment in the past 2 years other than non-malignant skin cancers
  • •Uncontrolled hypertension (Blood pressure 160/100 or greater)
  • •Hemoglobin A1c > 10%
  • •Recent CV event in past 6 months
  • •Pregnancy, childbirth, or nursing within prior 6 months
  • •Eating Attitudes Test (EAT-26) > 30
  • •Current major depressive disorder with Center for Epidemiological Studies Depression Scale-Revised (CESD-R) score > 16
  • •Schizophrenia, history of bipolar disorder
  • •Recent hospitalization for psychiatric illness in past 6 months
  • •Dependence on alcohol or sedative-hypnotic drugs
  • •Intolerance or allergy to Optifast product
  • •Unable to read/speak English
  • •Orthopedic limitation preventing participation in regular physical activity
  • •Untreated thyroid disease, abnormal TSH, non on stable dose of hormone replacement for hyperthyroidism
  • •Major surgery defined as any surgical procedure that might require prolonged convalescence or limit participation in the program in any way
  • •Inability to complete the 7-day run-in satisfactorily

研究组 & 干预措施

Intervention group, Optifast

Experimental

OPTIFAST, medically supervised weight-management program

干预措施: Optifast (Other)

Control group, Low-energy, low-fat

Active Comparator

Food-based program, current standard of care for weight management

干预措施: Food-Based (Other)

结局指标

主要结局

Percent weight change

时间窗: 52 weeks

Percent change in body weight between Initial Visit/Baseline and 52 weeks

Percent weight change

时间窗: 26 weeks

Percent change in body weight between Initial Visit/Baseline and 26 weeks

次要结局

  • Ability to meet weight goals(52 weeks)
  • Change in anthropometrics(52 weeks)
  • Change in cardiometabolic outcomes(52 weeks)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

Effectiveness of the Optifast Program Compared With... | 临床试验